Extended treatment with selective phosphatidylinositol 3‐kinase and mTOR inhibitors has effects on metabolism, growth, behaviour and bone strength

Publisher： John Wiley & Sons Inc

E-ISSN： 1742-4658|280|21|5337-5349

ISSN： 1742-464x

Source： FEBS JOURNAL (ELECTRONIC), Vol.280, Iss.21, 2013-11, pp. : 5337-5349

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Phosphatidylinositol 3-Kinase/mTor Pathway as a Therapeutic Target for Brain Aging and Neurodegeneration

By Heras-Sandoval David Avila-Muñoz Evangelina Arias Clorinda

Pharmaceuticals, Vol. 4, Iss. 8, 2011-08 ,pp. : 1070-1087

MDPI

Access to resources Recommend Favorite

Effects of mTOR Inhibitors on Components of the Salvador-Warts-Hippo Pathway

By Chiang Jonathan Martinez-Agosto Julian A.

Cells, Vol. 1, Iss. 4, 2012-10 ,pp. : 886-904

MDPI

Access to resources Recommend Favorite

Role of mTOR Inhibitors in Kidney Disease

By Kajiwara Moto Masuda Satohiro

International Journal of Molecular Sciences, Vol. 17, Iss. 6, 2016-06 ,pp. : 975-975

MDPI

Access to resources Recommend Favorite

Inhibition of CCL2 Signaling in Combination with Docetaxel Treatment Has Profound Inhibitory Effects on Prostate Cancer Growth in Bone

By Kirk Peter S. Koreckij Theodore Nguyen Holly M. Brown Lisha G. Snyder Linda A. Vessella Robert L. Corey Eva

International Journal of Molecular Sciences, Vol. 14, Iss. 5, 2013-05 ,pp. : 10483-10496

MDPI

Access to resources Recommend Favorite

Resveratrol as a novel treatment for diseases with mTOR pathway hyperactivation

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, Vol. 1348, Iss. 1, 2015-08 ,pp. : 116-123

John Wiley & Sons Inc

Access to resources Recommend Favorite